Health Services Research
Latest posts by Health Services Research (see all)
- Postponing a General Practitioner Visit: Describing Social Differences in Thirty-One European… - Feb. 20, 2017
- Impact of Provider Competition under Global Budgeting on the Use of Cesarean Delivery - Feb. 20, 2017
- Home Health Care: Nurse–Physician Communication, Patient Severity, and Hospital Readmission - Feb. 20, 2017
- Identifying Primary Care Pathways from Quality of Care to Outcomes and Satisfaction Using… - Feb. 20, 2017
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.